ArticleJournal of bone oncology2022

Pexmetinib suppresses osteoclast formation and breast cancer induced osteolysis via P38/STAT3 signal pathway.

Zhiwei Jie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.